Alan B. Fleischer, Jr, MD

Articles by Alan B. Fleischer, Jr, MD

The Duration of Office Visits in the United States, 1993 to 2010

ByMeredith K. Shaw,Scott A. Davis, MA,Alan B. Fleischer, Jr, MD,Steven R. Feldman MD, PhD

October 16th 2014

Nationally representative data show that outpatient office visits to both primary care physicians and specialists grew longer over the period from 1993 to 2010.

Analysis of Factors Associated With Increased Prescription Illegibility: Results From the National Ambulatory Medical Care Survey, 1990-1998

ByAditya K. Gupta, MD, PhD, FRCP(C),Elizabeth A. Cooper BSc, BESc,Steven R. Feldman MD, PhD,Alan B. Fleischer, Jr, MD,Rajesh Balkrishnan, PhD

August 1st 2003

Capitation Payment, Length of Visit, and Preventive Services: Evidence from a National Sample of Outpatient Physicians

ByRajesh Balkrishnan, PhD,Mark A. Hall, JD,Don Mehrabi, BS,G. John Chen, MD, PhD,Steven R. Feldman MD, PhD,Alan B. Fleischer, Jr, MD

April 1st 2002

Are Patients' Chief Complaints Generally Specific to One Organ System?

ByAlan B. Fleischer, Jr, MD,Elizabeth F. Gardner, BS,Steven R. Feldman MD, PhD

March 1st 2001

Diagnosis of Skin Disease by Nondermatologists

ByAlan B. Fleischer, Jr, MD,Courtney-Regan Herbert, MPH,Steven R. Feldman MD, PhD,Frances O'Brien, MD

October 1st 2000

Is Prior Authorization of Topical Tretinoin for Acne Cost Effective?

BySteven R. Feldman MD, PhD,Alan B. Fleischer, Jr, MD,G. John Chen, PhD

April 1st 1999

Latest Updated Articles

The Duration of Office Visits in the United States, 1993 to 2010
October 16th 2014
Are Patients' Chief Complaints Generally Specific to One Organ System?
March 1st 2001
Is Prior Authorization of Topical Tretinoin for Acne Cost Effective?
April 1st 1999
Analysis of Factors Associated With Increased Prescription Illegibility: Results From the National Ambulatory Medical Care Survey, 1990-1998
August 1st 2003
Capitation Payment, Length of Visit, and Preventive Services: Evidence from a National Sample of Outpatient Physicians
April 1st 2002
Diagnosis of Skin Disease by Nondermatologists
October 1st 2000

Alan B. Fleischer, Jr, MD

Articles by Alan B. Fleischer, Jr, MD

The Duration of Office Visits in the United States, 1993 to 2010

Analysis of Factors Associated With Increased Prescription Illegibility: Results From the National Ambulatory Medical Care Survey, 1990-1998

Capitation Payment, Length of Visit, and Preventive Services: Evidence from a National Sample of Outpatient Physicians

Are Patients' Chief Complaints Generally Specific to One Organ System?

Diagnosis of Skin Disease by Nondermatologists

Is Prior Authorization of Topical Tretinoin for Acne Cost Effective?

Latest Updated Articles

Trending on AJMC

ATTR-CM Incidence, Prevalence Rose Sharply in the US

CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes

First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention

Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC

Natera's Moshkevich Discusses TOMR Approach and the Future of MRD-Guided Care

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Alan B. Fleischer, Jr, MD

Articles by Alan B. Fleischer, Jr, MD

The Duration of Office Visits in the United States, 1993 to 2010

Analysis of Factors Associated With Increased Prescription Illegibility: Results From the National Ambulatory Medical Care Survey, 1990-1998

Capitation Payment, Length of Visit, and Preventive Services: Evidence from a National Sample of Outpatient Physicians

Are Patients' Chief Complaints Generally Specific to One Organ System?

Diagnosis of Skin Disease by Nondermatologists

Is Prior Authorization of Topical Tretinoin for Acne Cost Effective?

Latest Updated Articles

Trending on AJMC

ATTR-CM Incidence, Prevalence Rose Sharply in the US

CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes

First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention

Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC

Natera's Moshkevich Discusses TOMR Approach and the Future of MRD-Guided Care